[vc_row][vc_column][vc_column_text]Assorted news links from the last week:

Study Offers Insights on Health Problems among AYA Cancer Survivors

Medical trial aims to identify those at risk of heart damage following cancer treatment Australian researchers taking a very broad look at the effect of cancer treatment on heart health.

Racial Disparities in Pediatric Cancer Treatment: Black Children Less Likely to Receive Proton Radiotherapy, Forbes

US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG, a big win for the Creating Hope Act (which needs to be permanently reauthorized by the end of September)

Risk-Stratified Therapy Reduces Late Morbidity, Mortality in Pediatric Acute Lymphoblastic Leukemia

Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared

Preserving Childhood Cancer Care Amid a Pandemic, U.S. News & World Report

Scientists Focus on Fusion Proteins in Childhood Cancers[/vc_column_text][/vc_column][/vc_row]